Surgical reconstruction of the mandible and maxilla: A health technology assessment in the Australian context
Access status:
Open Access
Type
ThesisThesis type
Doctor of PhilosophyAuthor/s
Petrides, George AndrewAbstract
Surgical resection of the mandible and maxilla is a standard treatment for jaw pathology, including tumours, trauma, infection, and osteonecrosis. Jaw resection profoundly impacts health-related quality of life (HRQoL) through impairments in aesthetics, speech, swallowing, and ...
See moreSurgical resection of the mandible and maxilla is a standard treatment for jaw pathology, including tumours, trauma, infection, and osteonecrosis. Jaw resection profoundly impacts health-related quality of life (HRQoL) through impairments in aesthetics, speech, swallowing, and mastication. Microvascular free flap reconstruction is the current gold-standard, with adjuncts including virtual surgical planning (VSP) and immediate dental rehabilitation increasingly utilised for their link to improved outcomes. Jaw reconstruction is one of the most resource-intensive procedures in head and neck surgery, yet considerable gaps in the economic literature preclude evidence-based decision-making. This thesis addresses these gaps through five interrelated studies. A scoping review (Study 1) identified 36 studies, finding personnel costs as the primary cost-driver, but only 8% conducted full economic evaluations. Study 2, a micro-costing study of 100 patients, established a mean direct admission cost of A$54,988, with ward staffing, disposables, prostheses/VSP, and operating room staffing as the largest contributors. Study 3, a cost-minimisation analysis of 64 patients, demonstrated that point-of-care VSP (POC-VSP) reduced costs by A$9,835 per case versus commercial VSP, with economies of scale favouring POC-VSP beyond seven cases annually. Study 4, a cost-reimbursement analysis of 61 privately insured patients, found that 93–100% of cases were loss-making when overhead costs were included, with mean deficits of A$26,066–A$49,540, regardless of reimbursement model. Study 5 mapped the FACE-Q Head and Neck Cancer instrument to the EQ-5D-5L using beta regression as the optimal framework, enabling derivation of QALYs from FACE-Q data for future cost-utility analyses. Collectively, this thesis establishes foundational economic evidence to inform clinical decision-making, resource allocation, and health policy for jaw reconstruction.
See less
See moreSurgical resection of the mandible and maxilla is a standard treatment for jaw pathology, including tumours, trauma, infection, and osteonecrosis. Jaw resection profoundly impacts health-related quality of life (HRQoL) through impairments in aesthetics, speech, swallowing, and mastication. Microvascular free flap reconstruction is the current gold-standard, with adjuncts including virtual surgical planning (VSP) and immediate dental rehabilitation increasingly utilised for their link to improved outcomes. Jaw reconstruction is one of the most resource-intensive procedures in head and neck surgery, yet considerable gaps in the economic literature preclude evidence-based decision-making. This thesis addresses these gaps through five interrelated studies. A scoping review (Study 1) identified 36 studies, finding personnel costs as the primary cost-driver, but only 8% conducted full economic evaluations. Study 2, a micro-costing study of 100 patients, established a mean direct admission cost of A$54,988, with ward staffing, disposables, prostheses/VSP, and operating room staffing as the largest contributors. Study 3, a cost-minimisation analysis of 64 patients, demonstrated that point-of-care VSP (POC-VSP) reduced costs by A$9,835 per case versus commercial VSP, with economies of scale favouring POC-VSP beyond seven cases annually. Study 4, a cost-reimbursement analysis of 61 privately insured patients, found that 93–100% of cases were loss-making when overhead costs were included, with mean deficits of A$26,066–A$49,540, regardless of reimbursement model. Study 5 mapped the FACE-Q Head and Neck Cancer instrument to the EQ-5D-5L using beta regression as the optimal framework, enabling derivation of QALYs from FACE-Q data for future cost-utility analyses. Collectively, this thesis establishes foundational economic evidence to inform clinical decision-making, resource allocation, and health policy for jaw reconstruction.
See less
Date
2026Rights statement
The author retains copyright of this thesis. It may only be used for the purposes of research and study. It must not be used for any other purposes and may not be transmitted or shared with others without prior permission.Faculty/School
Faculty of Medicine and HealthDepartment, Discipline or Centre
Central Clinical SchoolAwarding institution
The University of SydneyShare